Cargando…
Potential use of multikinase inhibitors in immunosuppressed patients with malignancies including thyroid cancer
In this article, we focus on a variety of immunosuppression scenarios and whether multikinase inhibitors, as systemic therapy for advanced thyroid carcinoma (TC), could be useful for the treatment of immunocompromised patients with TC. Lenvatinib and sorafenib, among other MKIs, have become the stan...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537054/ https://www.ncbi.nlm.nih.gov/pubmed/36202608 http://dx.doi.org/10.1002/cam4.5106 |